- Expression of type I plasminogen activator inhibitor in renal tissue in murine lupus
-
Ahn C
- KMID: 1694938
- Korean J Nephrol.
- 1991 Dec;10(4):474-485.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Differences in thrombolytic effects in accordance with dosing- resimens of tissue- type plasminogen activator in experimental pulmonary embolism
-
Chung HS, Kim HJ, Han YC
- KMID: 2049916
- Tuberc Respir Dis.
- 1993 Apr;40(2):123-134.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Relationship Between Diabetic Nephropathy and Plasminogen Activator Inhibitor-1
-
Cha BS, Kim HJ
- KMID: 1767996
- J Korean Diabetes Assoc.
- 2003 Jun;27(3):179-185.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Secretion of plasminogen activator by cultured bovine retinal endothelial cell:modulation by insulin-like growth factor-i
-
Kim DS, Kim EJ, Choi WH, Kim TW, Kim MH
- KMID: 1700080
- J Korean Diabetes Assoc.
- 1993 Dec;17(4):359-366.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of immune-mediated vascular injury on the coagulation- regulatory mechanism of the human endothelial cells; changes of tissue-type plasminogen activator, plasminogen activator inhibitor- 1 and von Willebrand factor
-
Park S, Song YW
- KMID: 1773319
- Korean J Intern Med.
- 1991 Feb;40(2):205-213.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Plasminogen activator inhibitor(PAI-1) and factor VIII in acute lung injury
-
Kim HJ, Ahn CM, Lee KJ, Kim SK, Lee WY, Song KS
- KMID: 1698024
- Korean J Intern Med.
- 1991 Dec;41(6):813-820.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Multiple Intracranial Hemorrhage Following Intravenous Recombinant Plasminogen Activator in the Patients Taking Rivaroxaban
-
Ryu JC, Kwon JH, Choi SH, Kim WJ
- KMID: 2370972
- J Korean Neurol Assoc.
- 2017 Feb;35(1):50-52.
- doi: 10.17340/jkna.2017.1.13
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Protracted Perihematomal Edema after Fibrinolysis Therapy with Urokinase
-
Seo DH
- KMID: 1515688
- Korean J Cerebrovasc Surg.
- 2003 Sep;5(2):153-157.
There is increasing evidence that thrombin is directly involved in the pathogenesis of cerebral edema after intracerebral hemorrhage. Some authors emphasize that early removal of hematoma using plasminogen activator can... -
- CITED
-
- Close
- SHARE
-
- Close
- Plasmin and Its Inhibitors in the Lesional Skin of Pemphigus
-
Lee CW
- KMID: 2231317
- Korean J Dermatol.
- 1988 Jun;26(3):292-297.
The exact pathomechanism of anti-epidermal cell pemphigus antibodies in developing acantholytic changes is unknown. Recent investigations have suggested that pemphigus antibodies, after binding to the antigenic site, induce activation of... -
- CITED
-
- Close
- SHARE
-
- Close
- Polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) gene in Kawasaki disease
-
Han MY
- KMID: 2278489
- Korean J Pediatr.
- 2007 Jun;50(6):570-575.
- doi: 10.3345/kjp.2007.50.6.570
PURPOSE: To demonstrate genetic background of pathogenesis of Kawasaki disease (KD), I examined the genetic polymorphism of plasminogen activator inhibitor-1 (PAI-1) in KD patients. METHODS: PCR-RFLP of PAI- 1 promotor... -
- CITED
-
- Close
- SHARE
-
- Close
- The Plasmin Activity in Tear Film and Chronic Corneal Ulcer
-
Yoon YD, Kim HB
- KMID: 1968196
- J Korean Ophthalmol Soc.
- 1991 Oct;32(10):844-849.
Plasmin is an enzyme which plays an important role in the inflammatory process by activating vasoactive amine and lysis of fibrin. On the other hand, plasmin is also known to... -
- CITED
-
- Close
- SHARE
-
- Close
- Plasminogen Activator Inhibitor-1 in Asthma
-
- KMID: 2090084
- Korean J Asthma Allergy Clin Immunol.
- 2004 Jun;24(2):176-185.
Plasminogen activator inhibitor (PAI)-1 is a serine protease that, in addition to its major role in hemostasis, is known to play an essential role in tissue remodeling. Recent evidence indicates... -
- CITED
-
- Close
- SHARE
-
- Close
- Plasmin System in Placenta from Women with Normal and Preeclamptic Pregnancy
-
Roh CR, Lee JH, Yoon BK
- KMID: 2261361
- Korean J Obstet Gynecol.
- 1999 Mar;42(3):539-543.
OBJECTIVES: the aim of this study was to evaluate plasmin system in placenta fiom women with normal and preeclamptic pregnancy. METHODS: The levels of urokinase-type plasminogen activator(uPA), tissue-type plasrninogen activator(tPA),... -
- CITED
-
- Close
- SHARE
-
- Close
- Plasminogen Activator Inhibitor Type 1 Gene Polymorphism in Patients with Minimal Change Nephrotic Syndrome
-
Kim YM, Hong HK, Kim SD, Cho BS
- KMID: 2197650
- J Korean Soc Pediatr Nephrol.
- 2004 Apr;8(1):26-32.
PURPOSE: Hypercoagulability is present in patients with nephrotic syndrome. Plasminogen activator inhibitor type 1(PAI-1) is a major inhibitor of plasminogen activators. PAI-1 inactivates both tissue plasminogen activator(tPA) and urokinase plasminogen... -
- CITED
-
- Close
- SHARE
-
- Close
- The Difference of Thrombogenic and Fibrinolytic Factors inPremenopausal and Menopausal Women
-
Park CG, Oh DJ, Seo HS, Song WH, Lim DS, Lee EM, Ahn JC, Kim YH, Shim WJ, Ro YM
- KMID: 2029438
- Korean Circ J.
- 1997 Nov;27(11):1074-1081.
- doi: 10.4070/kcj.1997.27.11.1074
BACKGROUND: Thrombotic and fibrinolytic factors which change in women following menopause, may be of pathogenetic importance in atherogenetic and thrombotic cardiovascular diseases by altering fibrinolysis on vascular surfaces. We investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- Auranofin Suppresses Plasminogen Activator Inhibitor-2 Expression through Annexin A5 Induction in Human Prostate Cancer Cells
-
Shin DW, Kwon YJ, Ye DJ, Baek HS, Lee JE, Chun YJ
- KMID: 2375038
- Biomol Ther.
- 2017 Mar;25(2):177-185.
- doi: 10.4062/biomolther.2016.223
Auranofin has been developed as antirheumatic drugs, which is currently under clinical development for the treatment of chronic lymphocytic leukemia. Previous report showed that auranofin induced apoptosis by enhancement of... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of the Coagulation and Fibrinolytic Pathway in Acute Lung Injury
-
Kwak SH
- KMID: 2228346
- Korean J Crit Care Med.
- 2009 Aug;24(2):53-58.
- doi: 10.4266/kjccm.2009.24.2.53
Acute lung injury (ALI) is a common, life-threatening cause of acute respiratory failure, which is ultimately caused by a variety of local and systemic insults. Alterations in the coagulation and... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of Urokinase-type Plasminogen Activator (uPA) and Plasminogen Activator Inhibitor-1 (PAI-1) in Gallbladder Carcinoma
-
Lee KH, Kang HJ, Lee SY, Park MH
- KMID: 1979366
- Korean J Pathol.
- 2003 Dec;37(6):384-392.
BACKGROUND: There are evidences that uPA and its inhibitor play a key role in tumor spread. We studied whether uPA and PAI-1 expressions could serve as prognostic parameters along with... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical significance of plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in chronic stable angina
-
Choi YJ, Park SS, Park SW, Sohn DW, Oh BH, Lee MM, Park YB, Choi YS, Seo JD, Lee YW
- KMID: 2229227
- Korean Circ J.
- 1993 Jun;23(3):356-362.
- doi: 10.4070/kcj.1993.23.3.356
BACKGROUND: Impaired fibrinolytic system has been considered to play an important role in the pathogenesis of coronary artery disease, especially associated with thrombus formation. To evaluate the pathogenetic role of... -
- CITED
-
- Close
- SHARE
-
- Close
- Plasminogen Activator Inhibitor-1 (PAI-1)/tissue Plasminogen Activator (t-PA) Levels and PAI-1 4G/5G Promoter Polymorphism in Type 2 Diabetes with Microalbuminuria
-
Kwon SH, Park YJ, Jeong IK, Koh JJ, Park KS, Kim SY, Lee HK
- KMID: 1767997
- J Korean Diabetes Assoc.
- 2003 Jun;27(3):186-198.
BACKGROUND: Persistent microalbuminuria in diabetic patients is a risk factor of cardiovascular mortality. Increased plasma plasminogen activator inhibitor type-1 (PAI-1) levels have been observed in diabetic patients with overt nephropathy.... -
- CITED
-
- Close
- SHARE
-
- Close
